MXPA04000386A - COMPOSICIONES Y MeTODOS PARA LA ADMINISTRACION DE AGENTES QUE SE UNEN A LA TUBULINA PARA EL TRATAMIENTO DE ENFERMEDADES OCULARES. - Google Patents

COMPOSICIONES Y MeTODOS PARA LA ADMINISTRACION DE AGENTES QUE SE UNEN A LA TUBULINA PARA EL TRATAMIENTO DE ENFERMEDADES OCULARES.

Info

Publication number
MXPA04000386A
MXPA04000386A MXPA04000386A MXPA04000386A MXPA04000386A MX PA04000386 A MXPA04000386 A MX PA04000386A MX PA04000386 A MXPA04000386 A MX PA04000386A MX PA04000386 A MXPA04000386 A MX PA04000386A MX PA04000386 A MXPA04000386 A MX PA04000386A
Authority
MX
Mexico
Prior art keywords
treatment
compositions
methods
tubulin binding
binding agents
Prior art date
Application number
MXPA04000386A
Other languages
English (en)
Inventor
Sherris David
Original Assignee
Oxigene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxigene Inc filed Critical Oxigene Inc
Priority claimed from PCT/US2002/022449 external-priority patent/WO2003006002A1/en
Publication of MXPA04000386A publication Critical patent/MXPA04000386A/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion esta dirigida a la administracion de agentes dirigidos a los vasos sanguineos, particularmente, un agente que se une a la tubulina, para el tratamiento de la neovascularizacion ocular, los tumores oculares, y condiciones tales como la retinopatia diabetica, la retinopatia de la premadurez, el retinoblastoma y la degeneracion macular.
MXPA04000386A 2001-07-13 2002-07-15 COMPOSICIONES Y MeTODOS PARA LA ADMINISTRACION DE AGENTES QUE SE UNEN A LA TUBULINA PARA EL TRATAMIENTO DE ENFERMEDADES OCULARES. MXPA04000386A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38622701P 2001-07-13 2001-07-13
US37755602P 2002-05-03 2002-05-03
US33784702P 2002-05-03 2002-05-03
US37784502P 2002-05-03 2002-05-03
PCT/US2002/022449 WO2003006002A1 (en) 2001-07-13 2002-07-15 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases

Publications (1)

Publication Number Publication Date
MXPA04000386A true MXPA04000386A (es) 2004-05-04

Family

ID=34109074

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000386A MXPA04000386A (es) 2001-07-13 2002-07-15 COMPOSICIONES Y MeTODOS PARA LA ADMINISTRACION DE AGENTES QUE SE UNEN A LA TUBULINA PARA EL TRATAMIENTO DE ENFERMEDADES OCULARES.

Country Status (1)

Country Link
MX (1) MXPA04000386A (es)

Similar Documents

Publication Publication Date Title
MX2007008848A (es) Metodos y composiciones para el tratamiento de desordenes oculares.
WO2002058730A3 (en) Compositions for treatment of ocular neovascularization
WO2001051087A3 (en) Novel treatment for eye disease
CY1107074T1 (el) Συνθεση εναντιομερων 4-αμινο-θαλιδομιδης
TW200633709A (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
MX2010003774A (es) Formulaciones oftalmicas acuosas.
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
MXPA05006940A (es) Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
EP2662089A3 (en) Compstatin and analogs thereof for eye disorders
MX2009002893A (es) Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
WO2005120461A3 (en) Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
WO2007046083A3 (en) Compositions for treatment of eye diseases
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
WO2006073786A3 (en) Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
MX2007010996A (es) Nuevas composiciones de liposomas.
WO2003057259A3 (en) Indocyanine green (icg) compositions
TW200628473A (en) Novel heterocycles
WO2006039252A3 (en) Compositions and methods for treating ophthalmic diseases
WO2008054639A3 (en) Use of a catechin or polyphenol to treat ocular diseases and infection
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
WO2002009702A3 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
MX2007004030A (es) Analogos de poliamina como agentes terapeuticos para enfermedades oculares.
WO2003006002A8 (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
WO2004016214A3 (en) Methods and compositions for treatment of macular and retinal disease

Legal Events

Date Code Title Description
FG Grant or registration